STAGE IVB HYPOPHARYNGEAL CARCINOMA AJCC V8
Clinical trials for STAGE IVB HYPOPHARYNGEAL CARCINOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IVB HYPOPHARYNGEAL CARCINOMA AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IVB HYPOPHARYNGEAL CARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to boost chemoradiation for head and neck cancer
Disease control Recruiting nowThis early-phase study tests whether adding the experimental drug ipatasertib to standard chemotherapy and radiation is safe for people with advanced head and neck cancer. Ipatasertib may help stop cancer cells from growing. The study involves about 46 adults and aims to find the…
Matched conditions: STAGE IVB HYPOPHARYNGEAL CARCINOMA AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC
-
New scan method reveals hidden radiation damage to neck arteries
Knowledge-focused Recruiting nowThis study aims to see if a special PET/CT scan using sodium fluoride can better detect radiation damage to neck blood vessels than the standard scan in 20 adults with head and neck cancers. Participants will get both types of scans before and after radiation therapy. The goal is…
Matched conditions: STAGE IVB HYPOPHARYNGEAL CARCINOMA AJCC V8
Phase: EARLY_PHASE1 • Sponsor: Emory University • Aim: Knowledge-focused
Last updated May 01, 2026 15:38 UTC